Shirley A. Weis - 13 May 2026 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Reporting relationship: Director
Issuer ticker: MD
Reported as of: 13 May 2026
Net transaction value: -$855,665
SEC form: 4
Accepted by SEC: 14 May 2026, 17:00:04 UTC
Prior SEC filing: 11 May 2026
Next SEC filing: 14 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Mary Ann E. Moore, Attorney-in-Fact

Key filing fact

Shirley A. Weis filed Form 4 for Pediatrix Medical Group, Inc. (MD) on 14 May 2026.

Key facts

This page summarizes Shirley A. Weis's Form 4 filing for Pediatrix Medical Group, Inc. (MD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 May 2026, 17:00.

Change

Previous filing in this sequence was filed on 11 May 2026.
Current net transaction value: -$855,665.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001623324 Primary reporting owner

Weis Shirley A

Relationship: Director
Address: 1301 CONCORD TERRACE, SUNRISE
Signature: /s/ Mary Ann E. Moore, Attorney-in-Fact
Signature date: 14 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MD transaction

Common Stock

Sale

Transaction value: $855,665
Shares: -36,028
Change %: -100%
Price: $23.75
Shares after: 0
Date: 13 May 2026
Ownership: By The Weis Family Trust U/A dtd 04/19/2002, John N. Weis & Shirley A. Weis Trustees
Footnotes: F1, F2

MD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 18,623
Date: 13 May 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $23.55 to $23.85 for a weighted average sales price of $23.75. The reporting person undertakes to provide the issuer, any security holder of the issuer of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F2

The reporting person and her husband are trustees of the trust that holds the reported securities. Members of the reporting person's immediate family are beneficiaries of the trust.